搜尋結果
Gilead Foundation Awards $20 Million to Organizations Working to Advance Health Through ...
ACCESSWIRE· 2 年前Gilead Sciences, Inc. (Nasdaq:GILD) recently announced that the Gilead Foundation's ...
Lung Cancer Is Personal: Interview With Lee James
ACCESSWIRE· 2 年前NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Bristol Myers Squibb Company non-small cell ...
Direct Relief, Amgen and C/Can Team Up To Improve Access to Breast Cancer Diagnostics and ...
ACCESSWIRE· 2 年前Direct Relief today announced the launch of a joint, multi-year initiative with Amgen and the ...
Key Insights on Current and Emerging Healthcare Issues
ACCESSWIRE· 2 年前The Quest Diagnostics Health Trends® series of reports are drawn from our billions of data ...
Gilead Sciences: Metastatic Breast Cancer Advocate Urges Black People to Join Clinical Trials
ACCESSWIRE· 2 年前In the spring of 2018, North Carolina native Stephanie Walker went to her first breast cancer ...
Merck and Moderna Announce Exercise of Option by Merck for Joint Development and ...
ACCESSWIRE· 2 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
The Robert A. Winn Diversity in Clinical Trials Award Program Announces the Second Group of ...
ACCESSWIRE· 2 年前The Bristol Myers Squibb Foundation (BMSF), together with Virginia Commonwealth University ...
A Beacon of Hope
ACCESSWIRE· 2 年前Bristol Myers Squibb has a long-standing partnership with The Leukemia & Lymphoma Society (LLS) and has been the top biopharma ...
「太極」能改善末期肺癌患者睡眠質量 延長壽命
明日科學 via Yahoo奇摩新聞· 2 週前香港大學醫學院的最新研究發現，太極作為一種非藥物介入方法，不僅能顯著提高末期肺癌患者的睡眠質量，還可能延長其生存期。這項研究由研究助理教授高木直美博 ...
信達生物聯合禮來製藥宣佈達伯舒（信迪利單抗注射液）聯合化療用於一線治療食管鱗癌獲得國家藥品監督 ...
PR Newswire Asia· 2 年前美國舊金山、印第安納波利斯和中國蘇州2022年6月21日 /美通社/ -- 信達生物製藥集團（香港聯交所股票代碼：01801），一家致力於研發、生產和銷售腫瘤、自身 ...
